| Name | 1-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)uracil |
|---|---|
| Synonyms |
(2R,3R,4R,5R)-5-((benzoyloxy)methyl)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate
2’-C-Methyl -2’,3’,5’-tri-O-benzoyluridine 1-(2,3,5-Tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione 2'-C-Methyl-, 2',3',5'-tribenzoateuridine 2'-C-Methyl-2',3',5'-tribenzoyluridine 2'-C-Methyl -2',3',5'-tri-O-benzoyluridine Uridine, 2'-C-methyl-, 2',3',5'-tribenzoate 1-(2,3,5-Tri-O-benzoyl-2-C-Methyl-β-D-ribofuranosyl)uracil 2'-C-Methyl-,2',3',5'-tribenzoateuridine 2’-b-C-Methyl-2’,3’,5’-tribenzoyluridine 2’-β-C-Methyl -2’,3’,5’-tri-O-benzoyluridine 2,4(1H,3H)-Pyrimidinedione, 1-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl) SofosbuvirImpurity113 2'-C-Methyluridine 2',3',5'-tribenzoate 2'-C-METHYL-, 2',3',5'-TRIBENZOATEURIDINE |
| Description | 1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C31H26N2O9 |
| Molecular Weight | 570.55 |
| Exact Mass | 570.163818 |
| PSA | 142.99000 |
| LogP | 6.51 |
| Index of Refraction | 1.657 |
|
~%
23643-36-9 |
| Literature: Harry-O'kuru, Rogers E.; Kryjak, Emily A.; Wolfe, Michael S. Nucleosides and Nucleotides, 1997 , vol. 16, # 7-9 p. 1457 - 1460 |
|
~%
23643-36-9 |
| Literature: Harry-O'kuru, Rogers E.; Kryjak, Emily A.; Wolfe, Michael S. Nucleosides and Nucleotides, 1997 , vol. 16, # 7-9 p. 1457 - 1460 |
| Precursor 2 | |
|---|---|
| DownStream 3 | |